EBAG9 and B-cell chronic lymphocytic leukemia: Although there are some discrepancies between our study and previous studies in transplanted immune checkpoint blockade–treated mice, we also noted in Ebag9–/– CLL mice trends in T cell subset repair similar to programmed cell death ligand 1 blockade (38).